| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.054 | 0.05 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.061 | 0.06 |